Literature DB >> 3025625

Adenovirus E1a proteins repress expression from polyomavirus early and late promoters.

A Velcich, F G Kern, C Basilico, E B Ziff.   

Abstract

We have examined the effects of the E1a products of adenovirus types 5 and 12 on the expression of polyomavirus early and late promoters. In cotransfection experiments in HeLa cells, plasmids expressing the E1a region of adenovirus type 5 or 12 repressed both the early and late promoters of polyomavirus, and deletion analysis indicates that the polyomavirus enhancers were the target of the E1a repression. With mutants lacking enhancer sequences, the polyomavirus early promoter but not the late promoter was trans-activated by E1a. Chimeric mutant plasmids with deletions in the regulatory region that contained either the A enhancer or the B enhancer were repressed to the same extent, indicating that E1a can repress both elements. Polyomavirus variant plasmids with rearrangements in the regulatory region conferring activity in embryonal carcinoma stem cells were repressed by E1a as was the wild type, suggesting that the repressor function is quite general. We discuss a model in which the influence of E1a on the transcriptional activity of a gene is the sum of positive and negative effects on promoter and enhancer elements and discuss possible mechanisms of negative regulation of enhancer function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025625      PMCID: PMC367166          DOI: 10.1128/mcb.6.11.4019-4025.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Neoplastic differentiation: interaction of simian virus 40 and polyoma virus with murine teratocarcinoma cells in vitro.

Authors:  D E Swartzendruber; J M Lehman
Journal:  J Cell Physiol       Date:  1975-04       Impact factor: 6.384

2.  [Susceptibility of teratocarcinoma cells to simian virus 40 and polyoma virus (author's transl)].

Authors:  M Boccara; F Kelly
Journal:  Ann Microbiol (Paris)       Date:  1978 Feb-Mar

3.  An adenovirus type 5 early gene function regulates expression of other early viral genes.

Authors:  N Jones; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

4.  Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA IN NINE LINES OF TRANSFORMED RAT CELLS USING SPECIFIC FRAGMENTS OF THE VIRAL GENOME;.

Authors:  P H Gallimore
Journal:  J Mol Biol       Date:  1974-10-15       Impact factor: 5.469

5.  DNA sequences required for specific and efficient initiation of transcription at the polyoma virus early promoter.

Authors:  P Jat; U Novak; A Cowie; C Tyndall; R Kamen
Journal:  Mol Cell Biol       Date:  1982-07       Impact factor: 4.272

6.  Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses.

Authors:  M Perricaudet; G Akusjärvi; A Virtanen; U Pettersson
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

7.  Coding potential and regulatory signals of the polyoma virus genome.

Authors:  E Soeda; J R Arrand; N Smolar; J E Walsh; B E Griffin
Journal:  Nature       Date:  1980-01-31       Impact factor: 49.962

8.  Mechanism of activation of early viral transcription by the adenovirus E1A gene product.

Authors:  J R Nevins
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

9.  Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA.

Authors:  A Houweling; P J van den Elsen; A J van der Eb
Journal:  Virology       Date:  1980-09       Impact factor: 3.616

10.  Expression of early adenovirus genes requires a viral encoded acidic polypeptide.

Authors:  R P Ricciardi; R L Jones; C L Cepko; P A Sharp; B E Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  29 in total

1.  A DNA element that regulates expression of an endogenous retrovirus during F9 cell differentiation is E1A dependent.

Authors:  B T Lamb; K Satyamoorthy; D Solter; A Basu; M Q Xu; R Weinmann; C C Howe
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

2.  DNA-binding properties of the E1A-associated 300-kilodalton protein.

Authors:  Y Rikitake; E Moran
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  Upstream DNA sequences determine different autoregulatory responses of the adenovirus types 5 and 3 E1A promoters.

Authors:  S N Jones; C Tibbetts
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

4.  The adenovirus Ela gene induces differentiation of F9 teratocarcinoma cells.

Authors:  X Montano; D P Lane
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

5.  A novel E1A domain mediates skeletal-muscle-specific enhancer repression independently of pRB and p300 binding.

Authors:  A Sandmöller; H Meents; H H Arnold
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

6.  Negative and positive factors determine the activity of the polyoma virus enhancer alpha domain in undifferentiated and differentiated cell types.

Authors:  B Wasylyk; J L Imler; B Chatton; C Schatz; C Wasylyk
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Adenovirus E1A gene autorepression: revertants of an E1A promoter mutation encode altered E1A proteins.

Authors:  P L Larsen; C Tibbetts
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  Multiple domains in the polyomavirus B enhancer are required for productive infection of F9 embryonal carcinoma cells.

Authors:  R W Tseng; F K Fujimura
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

Review 9.  Regulation of early adenovirus gene expression.

Authors:  J R Nevins
Journal:  Microbiol Rev       Date:  1987-12

10.  Pancreatic beta-cell-type-specific expression of the rat insulin II gene is controlled by positive and negative cellular transcriptional elements.

Authors:  J Whelan; D Poon; P A Weil; R Stein
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.